RU2448712C2 - Модуляция путей обмена простагландина/циклооксигеназы - Google Patents

Модуляция путей обмена простагландина/циклооксигеназы Download PDF

Info

Publication number
RU2448712C2
RU2448712C2 RU2009124917/15A RU2009124917A RU2448712C2 RU 2448712 C2 RU2448712 C2 RU 2448712C2 RU 2009124917/15 A RU2009124917/15 A RU 2009124917/15A RU 2009124917 A RU2009124917 A RU 2009124917A RU 2448712 C2 RU2448712 C2 RU 2448712C2
Authority
RU
Russia
Prior art keywords
epia
inflammatory
hydroxy
pgj2
group
Prior art date
Application number
RU2009124917/15A
Other languages
English (en)
Russian (ru)
Other versions
RU2009124917A (ru
Inventor
Эрнст ВЮЛЬФЕРТ (BE)
Эрнст ВЮЛЬФЕРТ
Original Assignee
Хантер-Флеминг Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Хантер-Флеминг Лимитед filed Critical Хантер-Флеминг Лимитед
Publication of RU2009124917A publication Critical patent/RU2009124917A/ru
Application granted granted Critical
Publication of RU2448712C2 publication Critical patent/RU2448712C2/ru

Links

Images

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
RU2009124917/15A 2006-11-30 2007-11-29 Модуляция путей обмена простагландина/циклооксигеназы RU2448712C2 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US86787306P 2006-11-30 2006-11-30
GB0623971.9 2006-11-30
GB0623971A GB0623971D0 (en) 2006-11-30 2006-11-30 Modulation of prostaglandin/cyclooxygenase metabolic pathways
US60/867,873 2006-11-30

Publications (2)

Publication Number Publication Date
RU2009124917A RU2009124917A (ru) 2011-01-10
RU2448712C2 true RU2448712C2 (ru) 2012-04-27

Family

ID=37671641

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2009124917/15A RU2448712C2 (ru) 2006-11-30 2007-11-29 Модуляция путей обмена простагландина/циклооксигеназы

Country Status (9)

Country Link
CN (1) CN101594861B (es)
DK (1) DK2097079T3 (es)
ES (1) ES2390182T3 (es)
GB (1) GB0623971D0 (es)
NZ (1) NZ577075A (es)
PT (1) PT2097079E (es)
RS (1) RS52453B (es)
RU (1) RU2448712C2 (es)
SI (1) SI2097079T1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI713972B (zh) * 2019-01-14 2020-12-21 大江生醫股份有限公司 改善呼吸道健康之益生菌株及其組合物與用途
TWI692359B (zh) * 2019-02-25 2020-05-01 大江生醫股份有限公司 乳酸菌的代謝產物及其用於護肺的用途
CN111777613A (zh) * 2019-04-03 2020-10-16 中国药科大学 嘧啶二酮并吲哚和吡啶酮并吲哚类化合物的制备及用途
CN113905732A (zh) * 2019-04-09 2022-01-07 纽罗比特科学有限公司 用于预防或治疗脊髓损伤或椎管狭窄的药物组合物
CN111394289B (zh) * 2019-12-20 2021-06-11 合肥康诺生物制药有限公司 一种基因工程菌及其应用，生产前列腺素e2的方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2258511C2 (ru) * 2000-06-29 2005-08-20 Хантэр-Флеминг Лимитед Нейропротекторные 7-бета-гидроксистероиды
RU2329049C2 (ru) * 2001-08-14 2008-07-20 Хантэр-Флеминг Лимитед Профилактическое и терапевтическое применение гидроксистероидов

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2363983A (en) * 2000-06-29 2002-01-16 Hunter Fleming Ltd Protection against neuronal damage using 7-hydroxyepiandrosterone
FR2829697B1 (fr) * 2001-09-14 2004-03-19 Mayoly Spindler Lab Derives 7-hydroxyles et 7-cetoniques des hormones steroides 3 beta-hydroxylees pour le traitement des maladies inflammatoires ou fonctionnelles de l'intestin

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2258511C2 (ru) * 2000-06-29 2005-08-20 Хантэр-Флеминг Лимитед Нейропротекторные 7-бета-гидроксистероиды
RU2329049C2 (ru) * 2001-08-14 2008-07-20 Хантэр-Флеминг Лимитед Профилактическое и терапевтическое применение гидроксистероидов

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Харкевич Д.А. Фармакология. - М.: Медицина, 1987, с.47, 48. *

Also Published As

Publication number Publication date
CN101594861A (zh) 2009-12-02
GB0623971D0 (en) 2007-01-10
CN101594861B (zh) 2013-06-12
DK2097079T3 (da) 2012-10-01
RS52453B (en) 2013-02-28
RU2009124917A (ru) 2011-01-10
SI2097079T1 (sl) 2012-10-30
ES2390182T3 (es) 2012-11-07
NZ577075A (en) 2012-01-12
PT2097079E (pt) 2012-09-24

Similar Documents

Publication Publication Date Title
Anagnostis et al. Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences
Li et al. Potential role of CYP1B1 in the development and treatment of metabolic diseases
WO2020244454A1 (zh) 五环三萜皂苷化合物的医药用途及其药物组合物
Valles et al. Estradiol or genistein prevent Alzheimer's disease-associated inflammation correlating with an increase PPARγ expression in cultured astrocytes
Jang et al. β-Amyloid-induced apoptosis is associated with cyclooxygenase-2 up-regulation via the mitogen-activated protein kinase–NF-κB signaling pathway
Docagne et al. Excitotoxicity in a chronic model of multiple sclerosis: neuroprotective effects of cannabinoids through CB1 and CB2 receptor activation
Antika et al. Dietary phlorizin enhances osteoblastogenic bone formation through enhancing β-catenin activity via GSK-3β inhibition in a model of senile osteoporosis
US20130023504A1 (en) Modulation of Prostaglandin/Cyclooxygenase Metabolic Pathways
RU2448712C2 (ru) Модуляция путей обмена простагландина/циклооксигеназы
Verma et al. Augmenter of liver regeneration: Mitochondrial function and steatohepatitis
Chen et al. Pathogenic mechanisms of glucocorticoid-induced osteoporosis
Lu et al. Resveratrol attenuates high fat diet-induced mouse cardiomyopathy through upregulation of estrogen related receptor-α
KR20010093825A (ko) 신규의 핵수용체 리간드
Yang et al. Aryl hydrocarbon receptor: From pathogenesis to therapeutic targets in aging-related tissue fibrosis
Zhang et al. Osteocalcin alleviates nonalcoholic fatty liver disease in mice through GPRC6A
Lyu et al. TGR5 agonist INT-777 mitigates inflammatory response in human endometriotic stromal cells: A therapeutic implication for endometriosis
WO2011107023A1 (zh) 一种防治代谢性疾病的化合物及其用途
JP2010511028A5 (es)
Shimada et al. Ciliary signaling in stem cells in health and disease: Hedgehog pathway and beyond
Jin et al. Prostaglandin signaling in ciliogenesis and development
WO2009067182A2 (en) Phospholipid compositions and uses thereof
Zhang et al. The molecular mechanism of chronic high-dose corticosterone-induced aggravation of cognitive impairment in APP/PS1 Transgenic Mice
Yang et al. Obesity induced by estrogen deficiency is associated with hypothalamic inflammation
Bhattarai et al. Inhibition of IKK-β: A new development in the mechanism of the anti-obesity effects of PTP1B inhibitors SA18 and SA32
US8343915B2 (en) Use of heat-shock protein 27 for cardiovascular disease prevention and treatment

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20161130